MarketScreener Homepage > Equities > Nasdaq > Guardant Health, Inc. GH

Report

Delayed Nasdaq - 03/05 04:00:00 pm
135.27	USD		+1.59%

03/02

GUARDANT HEALTH : Obtains CE Mark For Tumor Mutation Profiling Test

03/02

GUARDANT HEALTH : Guardant360® CDx Liquid Biopsy CE-Marked for Comprehensive Tumor Mutation Profiling Across All Solid Cancers

02/26

GUARDANT HEALTH : Morgan Stanley Adjusts Guardant Health's Price Target to $175 From $130, Maintains Overweight Rating

Calendar

Upcoming events on GUARDANT HEALTH, INC.

05/13/21
08/11/21
11/11/21
03/15/22

Past events on GUARDANT HEALTH, INC.

03/02/21 \| 11:10am
02/26/21 \| 04:20pm
02/24/21 \| 05:00pm
02/24/21 \| 04:05pm

Upcoming sector events for GUARDANT HEALTH, INC.

03/07/21		BIO-TECHNE CORPORATION : Association of Biomolecular Resource Facilities Exhibition
03/09/21 \| 10:20am		ACCELERON PHARMA INC. : Barclays Global Healthcare Conference
03/09/21 \| 11:30am		EXELIXIS, INC. : Barclays Global Healthcare Conference
03/09/21 \| 03:35pm		PPD, INC. : Barclays Global Healthcare Conference

More events

Past sector events for GUARDANT HEALTH, INC.

03/04/21 \| 12:10pm		GILEAD SCIENCES, INC. : Cowen & Co. Health Care Conference
03/04/21 \| 08:30am		ARGENX SE : FY 2020 Earnings Call
03/04/21		ARGENX SE : FY 2020 Earnings Release
03/03/21 \| 02:40pm		SAREPTA THERAPEUTICS, INC. : Cowen Health Care Conference

Annual publications

Annual results		2017	2018	2019	2020	2021 (e)
Sales M $	Released Forecast Spread	49,8	90,6 83,4 8,7%	214 206 3,9%	287 285 0,60%	369
Operating income (EBITDA) M $	Released Forecast Spread	-71,4	-85,8 -92,8 7,6%	-71,0 -76,5 7,3%	-85,2 -203 58%	-265
Operating profit (EBIT) M $	Released Forecast Spread		-92,9 -93,0 0,01%	-82,4 -86,3 4,6%	-255 -218 -17%	-317
Pre-Tax Profit (EBT) M $	Released Forecast Spread		-84,2 -99,0 15%	-69,7 -73,7 5,4%	-246 -211 -17%	-279
Net income M $	Released Forecast Spread		-85,1 -93,2 8,7%	-75,7 -78,6 3,8%	-254 -218 -16%	-309
EPS $	Released Forecast Spread		-1,01 -1,10 7,9%	-0,84 -0,88 5,0%	-2,60 -2,19 -19%	-2,83
Announcement Date		09/06/2018	03/12/2019	02/24/2020	02/24/2021

Quarterly publications

Previous period

Next period

Quarterly results		2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1 (e)	2021 Q2 (e)	2021 Q3 (e)	2021 Q4 (e)	2022 Q1 (e)
Sales M $	Released Forecast Spread	21,7 17,4 24%	32,9 25,9 27%	36,7 31,6 16%	54,0 36,0 50%	60,8 45,4 34%	62,9 54,9 15%	67,5 55,4 22%	66,3 59,2 12%	74,6 66,0 13%	78,3 76,7 2,1%	75,2	85,3	97,2	108	112
Operating income (EBITDA) M $	Released Forecast Spread	-22,2 -22,3 0,34%	-25,2 -30,9 18%	-21,3 -30,6 30%	-12,6 -26,2 52%	-14,5 -34,4 58%	-22,5 -27,7 19%	-31,6 -36,3 13%	-50,8 -35,2 -44%	-69,9 -32,1 -118%	-29,8 -55,4 46%	-64,4	-61,8	-68,2	-70,2	-97,0
Operating profit (EBIT) M $	Released Forecast Spread	-24,2 -23,9 -1,5%	-27,4 -30,4 9,9%	-23,7 -32,0 26%	-15,3 -30,9 51%	-17,5 -33,2 47%	-26,0 -28,5 8,9%	-34,9 -40,5 14%	-54,6 -37,1 -47%	-74,3 -41,3 -80%	-91,2 -63,9 -43%	-86,3	-78,5	-87,2	-88,6	-80,8
Pre-Tax Profit (EBT) M $	Released Forecast Spread	-23,5 -24,0 2,1%	-25,2 -37,0 32%	-21,3 -33,5 36%	-12,5 -31,9 61%	-13,3 -34,0 61%	-22,6 -29,2 22%	-31,8 -39,2 19%	-49,7 -35,9 -39%	-71,6 -39,4 -82%	-92,8 -62,9 -47%	-83,1	-73,0	-81,8	-82,5	-77,8
Net income M $	Released Forecast Spread	-24,5 -23,9 -2,3%	-25,1 -31,6 21%	-26,1 -32,3 19%	-11,6 -31,9 64%	-12,8 -33,3 62%	-24,2 -28,5 15%	-27,7 -39,9 31%	-54,6 -35,1 -56%	-77,7 -40,3 -93%	-93,7 -62,5 -50%	-85,9	-77,8	-86,6	-88,2	-78,2
EPS $	Released Forecast Spread	-0,29 -0,27 -7,4%	-0,30 -0,35 15%	-0,30 -0,36 18%	-0,13 -0,35 63%	-0,14 -0,37 63%	-0,27 -0,31 12%	-0,29 -0,40 28%	-0,57 -0,38 -51%	-0,78 -0,40 -96%	-0,94 -0,59 -60%	-0,72	-0,65	-0,71	-0,71	-0,75
Announcement Date		11/19/2018	03/12/2019	05/09/2019	08/06/2019	11/07/2019	02/24/2020	05/07/2020	08/06/2020	11/05/2020	02/24/2021

Net sales (Year) - Rate of surprise

EPS (Year) - Rate of surprise

Net sales (Quarter) - Rate of surprise

EPS (Quarter) - Rate of surprise